Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study.

Gulati S, Wells JM, Urdaneta GP, Balestrini K, Vital I, Tovar K, Barnes JW, Bhatt SP, Campos M, Krick S.

Int J Mol Sci. 2019 May 9;20(9). pii: E2292. doi: 10.3390/ijms20092292.

2.

Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.

Barnes JW, Duncan D, Helton S, Hutcheson S, Kurundkar D, Logsdon NJ, Locy M, Garth J, Denson R, Farver C, Vo HT, King G, Kentrup D, Faul C, Kulkarni T, De Andrade JA, Yu Z, Matalon S, Thannickal VJ, Krick S.

Am J Physiol Lung Cell Mol Physiol. 2019 Jul 1;317(1):L141-L154. doi: 10.1152/ajplung.00246.2018. Epub 2019 May 1.

PMID:
31042083
3.

FGF23 Induction of O-Linked N-Acetylglucosamine Regulates IL-6 Secretion in Human Bronchial Epithelial Cells.

Krick S, Helton ES, Hutcheson SB, Blumhof S, Garth JM, Denson RS, Zaharias RS, Wickham H, Barnes JW.

Front Endocrinol (Lausanne). 2018 Nov 27;9:708. doi: 10.3389/fendo.2018.00708. eCollection 2018.

4.

Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases.

Garth J, Barnes JW, Krick S.

Int J Mol Sci. 2018 Oct 30;19(11). pii: E3402. doi: 10.3390/ijms19113402. Review.

5.

Things We "kNOw" and Do Not "kNOw" about Pulmonary Hypertension.

Barnes JW, Patel RP.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):151-152. doi: 10.1164/rccm.201803-0424ED. No abstract available.

6.

Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.

Barnes JW, Dweik RA.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1558-1560. doi: 10.1164/rccm.201704-0750ED. No abstract available.

7.

Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).

Barnes JW, Tonelli AR, Heresi GA, Newman JE, Mellor NE, Grove DE, Dweik RA.

Pulm Circ. 2016 Dec;6(4):439-447. doi: 10.1086/688847. Review. Erratum in: Pulm Circ. 2017 Apr-Jun;7(2):559.

8.

Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.

Heresi GA, Malin SK, Barnes JW, Tian L, Kirwan JP, Dweik RA.

Ann Am Thorac Soc. 2017 Feb;14(2):190-199. doi: 10.1513/AnnalsATS.201608-605OC.

9.

Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.

Barnes JW, Kucera ET, Tian L, Mellor NE, Dvorina N, Baldwin WW 3rd, Aldred MA, Farver CF, Comhair SA, Aytekin M, Dweik RA.

Am J Respir Cell Mol Biol. 2016 Oct;55(4):564-575.

10.

O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.

Barnes JW, Tian L, Heresi GA, Farver CF, Asosingh K, Comhair SA, Aulak KS, Dweik RA.

Circulation. 2015 Apr 7;131(14):1260-8. doi: 10.1161/CIRCULATIONAHA.114.013878. Epub 2015 Feb 6.

Supplemental Content

Loading ...
Support Center